Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3163.00    79.00 (2.56%)
Bid:
3161.00
Ask:
3164.00
Spread: 3.00 (0.095%)
Market Cap: £4.41b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Directorate Change

20 Apr 2018 11:14

RNS Number : 6351L
Croda International PLC
20 April 2018
 

The following amendment has been made to the Directorate Change announcement released on 20 April 2018 at 07:00 under RNS No 5187L.

 

Name amended from Robert to Roberto in the first paragraph.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

20 April 2018

 

 

Croda International Plc

 

 

Appointment of Non-Executive Directors - Board succession planning

 

 

The Board of Croda International Plc is pleased to announce the appointment of Roberto Cirillo and Jacqui Ferguson as non-executive directors. Roberto will join the Board with effect from 26 April 2018 and Jacqui will join with effect from 1 September 2018.

 

These appointments strengthen the Board's skills and experience in the areas of strategy, operations, international/emerging markets and digitalisation.

 

Roberto has worked in a number of international roles over the last 20 years, most recently as CEO of Optegra, the international eye healthcare company. Before that he was at Sodexo, where he played a critical role in the company's transformation and growth, working in a variety of roles, including in strategy and later as Group COO and as Country CEO of their French business. Prior to that Roberto worked as a consultant at Mckinsey & Company across many different areas and countries.

 

Jacqui has almost 30 years' experience in international roles in the technology sector. She held many senior operating roles at Hewlett Packard, including SVP & General Manager of HP's Enterprise Services Division in Europe whose business was to deliver digital and technology enabled transformations for enterprises. She was also Chief of Staff at Hewlett Packard working with the Chairman and CEO focused on a new company strategy and transformation. Prior to Hewlett Packard Jacqui worked for Electronic Data Systems, acquired by HP in 2008, and KPMG. Jacqui is currently a non-executive director of Wood Plc.

 

On joining the Board, both Jacqui and Roberto will also be appointed to the Audit, Nomination and Remuneration Committees. 

 

Anita Frew, Chairman of Croda International Plc, said,

 

"Both appointments will be of enormous benefit to the Croda Board, supporting our strategic plans to connect more dynamically to customers through the use of technology and helping customers transition to more sustainable ingredients. Roberto brings with him a wealth of international experience in operations and strategy and Jacqui a deep knowledge of digital as well as experience in operating in emerging markets. The appointments will also bring greater diversity to the Board in terms of gender, tenure, nationality and experience. We are delighted to welcome them both to the Croda Board.

 

"As previously announced, Nigel Turner will be retiring from the Board on 26 April 2018, at which time Alan Ferguson will take on the role of Senior Independent Director.

 

"Steve Williams will have served on the Board for nine years in 2019. In preparation for his retirement next year, Helena Ganczakowski will take over as Chairman of the Remuneration Committee with effect from 26 April 2018. This will give Helena a good period as Chairman to prepare for the Committee's review of the Company's remuneration policy at the end of the year. Helena has been a member of the Remuneration Committee since 1 February 2014.

 

"All these changes to the Board are consistent with the Board's approach to succession planning."

 

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

 

 

 

 

Enquiries:

 

Shareholders: Conleth Campbell, VP Investor Relations +44 1405 860 551

 

Press: Charlie Armistead, Teneo Blue Rubicon +44 203 603 5220

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAMMGZDGGZGRZM
Date   Source Headline
11th Jun 20262:58 pmRNSDirector/PDMR Shareholding
11th Jun 20269:15 amRNSDirector Declaration
1st Jun 20261:46 pmRNSDirector/PDMR Shareholding
29th May 20264:06 pmRNSDirector/PDMR Shareholding
29th May 20263:10 pmRNSDirector/PDMR Shareholding
29th May 20261:53 pmRNSDirector/PDMR Shareholding
29th May 20261:52 pmRNSDirector/PDMR Shareholding
29th May 20261:45 pmRNSDirector/PDMR Shareholding
15th May 20269:23 amRNSDirector/PDMR Shareholding
12th May 202612:10 pmRNSDirector/PDMR Shareholding
6th May 20261:21 pmRNSDirector/PDMR Shareholding
23rd Apr 202611:20 amRNSResult of AGM
22nd Apr 20267:00 amRNSFirst quarter 2026 sales in line with expectations
13th Apr 20261:41 pmRNSDirector/PDMR Shareholding
31st Mar 202611:48 amRNSHolding(s) in Company
26th Mar 20264:34 pmRNSDirector/PDMR Shareholding
18th Mar 20263:31 pmRNSDirector/PDMR Shareholding
18th Mar 20263:30 pmRNSDirector/PDMR Shareholding
18th Mar 20263:27 pmRNSDirector/PDMR Shareholding
18th Mar 20263:25 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:20 pmRNSDirector/PDMR Shareholding
16th Mar 20261:36 pmRNSAnnual Financial Report
16th Mar 20261:36 pmRNSAnnual Financial Report
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
6th Mar 20261:32 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:13 pmRNSHolding(s) in Company
24th Feb 20267:00 amRNSResults for the year ended 31 December 2025
11th Feb 20262:59 pmRNSDirector/PDMR Shareholding
13th Jan 20262:47 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSDirector Declaration
11th Dec 202511:30 amRNSDirector/PDMR Shareholding
11th Nov 202511:19 amRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSThird quarter 2025 sales update
14th Oct 20251:58 pmRNSDirector/PDMR Shareholding
8th Oct 20254:26 pmRNSDirector/PDMR Shareholding
1st Oct 20253:45 pmRNSDirector/PDMR Shareholding
18th Sep 20253:49 pmRNSHolding(s) in Company
12th Sep 202510:11 amRNSDirector/PDMR Shareholding
11th Sep 20253:54 pmRNSDirector/PDMR Shareholding
29th Aug 20253:58 pmRNSHolding(s) in Company
29th Aug 202511:03 amRNSHolding(s) in Company
27th Aug 20251:58 pmRNSHolding(s) in Company
22nd Aug 20254:24 pmRNSDirector/PDMR Shareholding
22nd Aug 202511:55 amRNSDirector/PDMR Shareholding
14th Aug 20259:10 amRNSDirector/PDMR Shareholding
12th Aug 202511:42 amRNSDirector/PDMR Shareholding
7th Aug 20259:16 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.